Goldman Sachs Invests $37M In Venture-Backed Venus Medtech
March 24, 2016 — 16:53 CST
This Data Is Locked!
This area is available only to Subscribers.
Goldman Sachs has agreed to invest US$37 million in Venus Medtech, a Hangzhou-based healthcare company focused on research and development of heart valves disease related... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals